Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Natural killer (NK) cell leukemia and lymphoma are rare hematologic malignancies.
• Diagnosis is challenging due to lack of specific markers, morphologic variability, and poor correlation with prognosis.
• Therapeutic strategies are based on limited retrospective data and case reports.

Purpose of the Study:

• To review the heterogeneous nature of NK-cell malignancies.
• To discuss diagnostic challenges and current therapeutic approaches.
• To highlight the varying prognoses associated with different NK-cell tumor subtypes.

Main Methods:

• Review of existing literature on NK-cell leukemia and lymphoma.
• Analysis of diagnostic criteria and immunophenotypic markers.
• Evaluation of treatment outcomes and prognostic factors.

Main Results:

• Immature NK-cell malignancies exhibit aggressive behavior and poor prognosis, with limited survival benefit from standard induction chemotherapy.
• High-dose chemotherapy with stem cell rescue may prolong survival in select cases.
• Mature NK-cell malignancies present a spectrum of disease, from aggressive leukemia with short survival to indolent T-cell large granular lymphocyte leukemia with long-term prognosis, often managed with low-dose chemotherapy or immunosuppressive therapy.

Conclusions:

• NK-cell malignancies are diverse, requiring tailored treatment strategies based on disease subtype and maturity.
• Accurate diagnosis and risk stratification are crucial for effective management.
• Further research is needed to develop targeted therapies for these rare cancers.